Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novasep was a France-based life sciences manufacturing and process-technology company focused on contract development and manufacturing, complex active pharmaceutical ingredients, and purification solutions for pharmaceutical and biopharmaceutical customers. Its core business centered on process development and cGMP manufacturing for small-molecule APIs, including highly potent compounds and ADC payload-related capabilities, alongside selected biopharmaceutical manufacturing services. Historically, Novasep also operated chromatography and purification equipment businesses, with that equipment division later integrated into Sartorius. In April 2022, Novasep merged with PharmaZell, and in October 2022 the Novasep, PharmaZell, and Farmabios brands were unified under the Axplora name. As a result, Novasep is best understood today as a legacy operating brand/business within Axplora rather than an independent standalone company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novsep.